title: [Treatment of fetal hemolytic disease using plasmapheresis].
abstract: Report about the therapy of severe Morbus haemolyticus fetalis in 15 pregnant women by plasmapheresis alone. Fetal survival rate was 67%. One of three children with hydrops fetalis survived. Plasmapheresis may be used in combination with intrauterine transfusion and improves treatment of Morbus haemolyticus fetalis.
authors.affiliation: Klinik für Gynäkologie und Geburtshilfe, des Bereichs Medizin der Wilhelm-Pieck-Universität Rostock.
authors.forename: G
authors.initials: G
authors.lastname: Schwarzlos
authors.forename: R
authors.initials: R
authors.lastname: During
authors.forename: S
authors.initials: S
authors.lastname: Müller
authors.forename: K H
authors.initials: KH
authors.lastname: Stark
authors.forename: R
authors.initials: R
authors.lastname: Plesse
mesh_terms: D004899:Erythroblastosis, Fetal / Q000628:therapy*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005865:Gestational Age; D006801:Humans; D007072:Immunoglobulin D / Q000276:immunology; D007231:Infant, Newborn; D007518:Isoantibodies / Q000032:analysis; D010956:Plasmapheresis; D011247:Pregnancy
chemical_list: D007072:Immunoglobulin D; D007518:Isoantibodies; C051138:anti-c antibody
vernacular_title: Therapie des Morbus haemolyticus fetalis mittels Plasmapherese.